Tradjenta
/
Tradjenta is an oral antihyperglycemic medication belonging to the DPP-4 inhibitor class, used to improve glycemic control in adults with type 2 diabetes mellitus. It is available as an oral tablet and is a prescription-only medication. Patients are advised that Tradjenta may cause severe allergic reactions and should not be used in individuals with a history of hypersensitivity to linagliptin or any of its components.
What is Tradjenta
Tradjenta is a prescription medication that contains the active ingredient linagliptin. It is used to improve blood sugar control in adults with type 2 diabetes mellitus, often in conjunction with diet and exercise. The drug works by inhibiting the enzyme DPP-4, which increases levels of incretin hormones, leading to enhanced insulin secretion and reduced glucagon levels. This helps to lower blood glucose levels after meals. Other medications in the same class include sitagliptin and saxagliptin, which are also DPP-4 inhibitors. Tradjenta is typically prescribed when other diabetes medications are not sufficient to control blood sugar levels.
Similar Drugs
25
commonly-prescribed
medication.